A |
2024-07-17 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
925.0000 |
925.0000 |
1 |
0001671584 |
Restricted Stock Unit |
D |
2024-06-02 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
81.0000 |
0.0000 |
4 |
0001671584 |
Restricted Stock Unit |
A |
2024-06-02 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
81.0000 |
277.0000 |
2 |
0001671584 |
Common Stock |
D |
2024-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
7.0000 |
0.0000 |
3 |
0001671584 |
Restricted Stock Unit |
A |
2024-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
7.0000 |
196.0000 |
1 |
0001671584 |
Common Stock |
D |
2023-08-09 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
3571.0000 |
0.0000 |
2 |
0001671584 |
Restricted Stock Unit |
A |
2023-08-09 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
3571.0000 |
8339.0000 |
1 |
0001671584 |
Common Stock |
A |
2023-06-02 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
3571.0000 |
3571.0000 |
3 |
0001671584 |
Restricted Stock Unit |
D |
2023-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
297.0000 |
298.0000 |
2 |
0001671584 |
Restricted Stock Unit |
A |
2023-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
297.0000 |
4768.0000 |
1 |
0001671584 |
Common Stock |
A |
2022-08-09 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
3571.0000 |
3571.0000 |
1 |
0001671584 |
Restricted Stock Unit |
D |
2022-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
298.0000 |
595.0000 |
2 |
0001671584 |
Restricted Stock Unit |
A |
2022-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
M-Exempt |
--D |
298.0000 |
8108.0000 |
1 |
0001671584 |
Common Stock |
A |
2021-06-04 |
|
REGENXBIO Inc. |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
1 |
0001590877 |
Stock Option (Right to Buy) |
A |
2021-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
893.0000 |
893.0000 |
2 |
0001671584 |
Restricted Stock Unit |
A |
2021-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
2678.0000 |
2678.0000 |
1 |
0001671584 |
Stock Option (right to buy) |
A |
2020-07-27 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
170.0000 |
170.0000 |
5 |
0001671584 |
Stock Option (right to buy) |
A |
2020-07-27 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
1322.0000 |
1322.0000 |
4 |
0001671584 |
Stock Option (right to buy) |
D |
2020-07-27 |
|
Aptevo Therapeutics Inc. |
4 |
D-Return |
--D |
1785.0000 |
0.0000 |
3 |
0001671584 |
Stock Option (right to buy) |
D |
2020-07-27 |
|
Aptevo Therapeutics Inc. |
4 |
D-Return |
--D |
892.0000 |
0.0000 |
2 |
0001671584 |
Stock Option (right to buy) |
D |
2020-07-27 |
|
Aptevo Therapeutics Inc. |
4 |
D-Return |
--D |
1339.0000 |
0.0000 |
1 |
0001671584 |
Stock Option (right to buy) |
A |
2020-07-02 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
3571.0000 |
3571.0000 |
1 |
0001671584 |
Stock Option (right to buy) |
A |
2020-05-29 |
|
REGENXBIO Inc. |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
1 |
0001590877 |
Stock Option (Right to Buy) |
A |
2019-06-25 |
|
Aptevo Therapeutics Inc. |
4 |
P-Purchase |
--D |
16667.0000 |
109351.0000 |
1 |
0001671584 |
Common Stock |
A |
2019-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
25000.0000 |
25000.0000 |
1 |
0001671584 |
Option (right to buy) |
A |
2019-05-31 |
|
REGENXBIO Inc. |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
1 |
0001590877 |
Stock Option (Right to Buy) |
D |
2019-03-04 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
14565.0000 |
142617.0000 |
1 |
0001367644 |
Common Stock |
D |
2019-02-28 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
5101.0000 |
157182.0000 |
3 |
0001367644 |
Common Stock |
D |
2019-02-27 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
2570.0000 |
162283.0000 |
2 |
0001367644 |
Common Stock |
D |
2019-02-26 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
1714.0000 |
164853.0000 |
1 |
0001367644 |
Common Stock |
A |
2018-09-17 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
1319.0000 |
0.0000 |
7 |
0001367644 |
Stock Option (Right to Buy) |
D |
2018-09-17 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
1319.0000 |
166567.0000 |
4 |
0001367644 |
Common Stock |
A |
2018-09-17 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
1319.0000 |
167886.0000 |
3 |
0001367644 |
Common Stock |
A |
2018-09-14 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
28220.0000 |
1319.0000 |
6 |
0001367644 |
Stock Option (Right to Buy) |
D |
2018-09-14 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
28220.0000 |
166567.0000 |
2 |
0001367644 |
Common Stock |
A |
2018-09-14 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
28220.0000 |
194787.0000 |
1 |
0001367644 |
Common Stock |
D |
2018-09-05 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
30776.0000 |
166567.0000 |
3 |
0001367644 |
Common Stock |
D |
2018-09-04 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
60000.0000 |
29539.0000 |
5 |
0001367644 |
Stock Option (Right to Buy) |
D |
2018-09-04 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
60000.0000 |
197343.0000 |
2 |
0001367644 |
Common Stock |
A |
2018-09-04 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
60000.0000 |
257343.0000 |
1 |
0001367644 |
Common Stock |
D |
2018-06-05 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
15785.0000 |
197343.0000 |
1 |
0001367644 |
Common Stock |
A |
2018-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
25000.0000 |
25000.0000 |
1 |
0001671584 |
Stock Option (right to buy) |
A |
2018-05-25 |
|
REGENXBIO Inc. |
4 |
A-Award |
--D |
12500.0000 |
12500.0000 |
1 |
0001590877 |
Stock Option (Right to Buy) |
D |
2018-03-09 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
7825.0000 |
213128.0000 |
1 |
0001367644 |
Common Stock |
D |
2018-02-28 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
6599.0000 |
220953.0000 |
4 |
0001367644 |
Common Stock |
A |
2018-02-27 |
|
Emergent BioSolutions Inc. |
4 |
A-Award |
--D |
53485.0000 |
53485.0000 |
6 |
0001367644 |
Employee Stock Option (right to buy) |
D |
2018-02-27 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
3324.0000 |
227552.0000 |
3 |
0001367644 |
Common Stock |
A |
2018-02-27 |
|
Emergent BioSolutions Inc. |
4 |
A-Award |
--D |
13371.0000 |
230876.0000 |
2 |
0001367644 |
Common Stock |
A |
2018-02-27 |
|
Emergent BioSolutions Inc. |
4 |
A-Award |
--D |
13371.0000 |
217505.0000 |
1 |
0001367644 |
Common Stock |
D |
2018-01-02 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
21906.0000 |
0.0000 |
4 |
0001367644 |
Stock Option (Right to Buy) |
D |
2018-01-02 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
21906.0000 |
204134.0000 |
2 |
0001367644 |
Common Stock |
A |
2018-01-02 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
21906.0000 |
226040.0000 |
1 |
0001367644 |
Common Stock |
D |
2017-12-13 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
20000.0000 |
21906.0000 |
4 |
0001367644 |
Stock Option (Right to Buy) |
D |
2017-12-13 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
20000.0000 |
204134.0000 |
2 |
0001367644 |
Common Stock |
A |
2017-12-13 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
20000.0000 |
224134.0000 |
1 |
0001367644 |
Common Stock |
D |
2017-11-03 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
20000.0000 |
41906.0000 |
7 |
0001367644 |
Stock Option (Right to Buy) |
D |
2017-11-03 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
11508.0000 |
0.0000 |
6 |
0001367644 |
Stock Option (Right to Buy) |
D |
2017-11-03 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
20000.0000 |
204134.0000 |
4 |
0001367644 |
Common Stock |
A |
2017-11-03 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
20000.0000 |
224134.0000 |
3 |
0001367644 |
Common Stock |
D |
2017-11-03 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
11508.0000 |
204134.0000 |
2 |
0001367644 |
Common Stock |
A |
2017-11-03 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
11508.0000 |
215642.0000 |
1 |
0001367644 |
Common Stock |
A |
2017-09-27 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
15000.0000 |
219134.0000 |
1 |
0001367644 |
Common Stock |
D |
2017-09-27 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
15000.0000 |
204134.0000 |
2 |
0001367644 |
Common Stock |
D |
2017-09-27 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
15000.0000 |
11508.0000 |
4 |
0001367644 |
Stock Option (Right to Buy) |
D |
2017-08-31 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
15000.0000 |
26508.0000 |
3 |
0001367644 |
Stock Option (Right to Buy) |
D |
2017-08-31 |
|
Emergent BioSolutions Inc. |
4 |
S-Sale |
--D |
15000.0000 |
204134.0000 |
2 |
0001367644 |
Common Stock |
A |
2017-08-31 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
15000.0000 |
219134.0000 |
1 |
0001367644 |
Common Stock |
A |
2017-06-01 |
|
Aptevo Therapeutics Inc. |
4 |
A-Award |
--D |
12500.0000 |
12500.0000 |
1 |
0001671584 |
Employee Stock Option (right to buy) |
A |
2017-05-24 |
|
REGENXBIO Inc. |
4 |
A-Award |
--D |
12500.0000 |
12500.0000 |
1 |
0001590877 |
Stock Option (Right to Buy) |
D |
2017-03-10 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
10738.0000 |
204134.0000 |
2 |
0001367644 |
Common Stock |
D |
2017-03-09 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
8226.0000 |
214872.0000 |
1 |
0001367644 |
Common Stock |
A |
2017-02-28 |
|
Emergent BioSolutions Inc. |
4 |
A-Award |
--D |
78329.0000 |
78329.0000 |
4 |
0001367644 |
Employee Stock Option (right to buy) |
D |
2017-02-28 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
6184.0000 |
223098.0000 |
3 |
0001367644 |
Common Stock |
A |
2017-02-28 |
|
Emergent BioSolutions Inc. |
4 |
A-Award |
--D |
19589.0000 |
229282.0000 |
2 |
0001367644 |
Common Stock |
A |
2017-02-28 |
|
Emergent BioSolutions Inc. |
4 |
A-Award |
--D |
19588.0000 |
209693.0000 |
1 |
0001367644 |
Common Stock |
A |
2017-02-27 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
3662.0000 |
192824.0000 |
1 |
0001367644 |
Common Stock |
D |
2017-02-27 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
1-D |
1735.0000 |
191089.0000 |
2 |
0001367644 |
Common Stock |
D |
2017-02-27 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
3662.0000 |
0.0000 |
4 |
0001367644 |
Stock Option - (Right to Buy) |
D |
2017-02-27 |
|
Emergent BioSolutions Inc. |
4 |
F-InKind |
--D |
984.0000 |
190105.0000 |
3 |
0001367644 |
Common Stock |
A |
2017-01-10 |
|
Emergent BioSolutions Inc. |
4 |
M-Exempt |
--D |
38006.0000 |
3662.0000 |
7 |
0001367644 |
Stock Option (Right to buy) |